Cerebral angiogenesis after subarachnoid hemorrhage (SAH) and endothelin receptor blockage with BQ-123 antagonist in rats

被引:0
|
作者
Josko, J
Hendryk, S
Jedrzejowska-Szypulka, H
Slowinski, J
Gwózdz, B
Lange, D
Snietura, M
Zwirska-Korczala, K
Jochem, J
机构
[1] Silesian Univ, Sch Med, Dept Physiol, PL-41808 Zabrze, Poland
[2] Silesian Univ, Sch Med, Dept Neurosurg & Neurotraumatol, Bytom, Poland
[3] Inst Oncol, Dept Tumor Pathol, Gliwice, Poland
来源
关键词
subarachnoid hemorrhage; endothelin-1; antagonist ETA receptors - BQ-123; angiogenesis;
D O I
暂无
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The aim of the study was to determine the effect of chronic vasospasm after SAH on angiogenesis and the effect of endothelin-1 the main causative factor in vasospasm, on this process. Male Wistar rats, 220-250 g, were examined. Seven days after cannulation of the cisterna magna (CM), a 100 mul dose of non-heparinized blood was administered to induce SAH. Sham SAH (aSAH) was induced by intracisternal injection of 100 mul of artificial cerebrospinal fluid. Endothelin receptor antagonist BQ-123 in a dose of 40 nmol in 50 mul of cerebrospinal fluid was given three times: 20 min. before SAH and aSAH, 60 min and 23 hours after SAH and aSAH. The same pattern of BQ-123 administration was used in the nonSAH group. The brains were removed 48 hours later for histological evaluation. Vascular surface density was measured in cerebral hemisphere sections (at the level of the dorsal part of the hippocampus) and brain stem sections (1/2 of the pens). An increase in angiogenesis was observed after SAH, compared to control values. The administration of BQ-123. a specific endothelin receptor blocker inhibits angiogenesis in cerebral hemispheres after SAH.
引用
收藏
页码:237 / 248
页数:12
相关论文
共 50 条
  • [31] Early therapeutic experience with the endothelin antagonist BQ-123 in pulmonary hypertension after congenital heart surgery
    Prendergast, B
    Newby, DE
    Wilson, LE
    Webb, DJ
    Mankad, PS
    HEART, 1999, 82 (04) : 505 - 508
  • [32] Cerebral vasospasm after aneurysmal subarachnoid hemorrhage is inhibited by clazosentan, an endothelin receptor antagonist
    Vajkoczy, P
    Meyer, B
    Weidauer, S
    Raabe, A
    Thome, C
    Ringel, FA
    Breu, V
    Schmiedek, P
    NEUROSURGERY, 2005, 57 (02) : 396 - 396
  • [33] Prevention of cerebral vasospasm after aneurysmal subarachnoid hemorrhage with clazosentan, an endothelin receptor antagonist
    MacDonald, Robert L.
    Kakarieka, A.
    Mayer, Stephan A.
    Pasqualin, Alberto
    Ruefenacht, D.
    Schmiedek, Peter
    Kassell, Neal F.
    NEUROSURGERY, 2006, 59 (02) : 453 - 453
  • [35] ANTIHYPERTENSIVE EFFECT OF A NEWLY SYNTHESIZED ENDOTHELIN ANTAGONIST, BQ-123, IN A GENETIC HYPERTENSIVE MODEL
    NISHIKIBE, M
    TSUCHIDA, S
    OKADA, M
    FUKURODA, T
    SHIMAMOTO, K
    YANO, M
    ISHIKAWA, K
    IKEMOTO, F
    LIFE SCIENCES, 1993, 52 (08) : 717 - 724
  • [36] Selective endothelin a (ETA) receptor antagonist (BQ-123) reduces both myocardial infarct size and oxidant injury
    Ozdemir, R
    Parlakpinar, H
    Polat, A
    Colak, C
    Ermis, N
    Acet, A
    TOXICOLOGY, 2006, 219 (1-3) : 142 - 149
  • [37] EFFECTS OF A SELECTIVE ENDOTHELIN A-RECEPTOR ANTAGONIST, BQ-123, IN SALT-LOADED STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS
    OKADA, M
    KOBAYASHI, M
    MARUYAMA, H
    TAKAHASHI, R
    IKEMOTO, F
    YANO, M
    NISHIKIBE, M
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1995, 22 (10) : 763 - 768
  • [38] EFFECT OF ENDOTHELIN RECEPTOR ANTAGONIST, BQ-123, ON CA-2+ SIGNALING IN CULTURED RAT MESANGIAL CELLS
    YOKOKAWA, K
    KOHNO, M
    JOHCHI, M
    HORIO, T
    MURAKAWA, K
    YASUNARI, K
    YANAGISAWA, M
    TAKEDA, T
    LIFE SCIENCES, 1993, 53 (21) : 1631 - 1641
  • [39] INVITRO BIOLOGICAL PROFILE OF A HIGHLY POTENT NOVEL ENDOTHELIN (ET) ANTAGONIST BQ-123 SELECTIVE FOR THE ET(A) RECEPTOR
    IHARA, M
    ISHIKAWA, K
    FUKURODA, T
    SAEKI, T
    FUNABASHI, K
    FUKAMI, T
    SUDA, H
    YANO, M
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 20 : S11 - S14
  • [40] BQ-123, a specific endothelin (ET(A)) receptor antagonist, prevents ischemia-reperfusion injury in kidney transplantation
    Buyukgebiz, O
    Aktan, AO
    Haklar, G
    Yalcin, AS
    Yegen, C
    Yalin, R
    Ercan, ZS
    TRANSPLANT INTERNATIONAL, 1996, 9 (03) : 201 - 207